FIELD: medicine.
SUBSTANCE: invention refers to medicine. What is presented is a method for the prediction of the postpartum osteopenic syndrome involving studying VDR gene polymorphism Fok-I and predicting the osteopenic syndrome having the genotypes Ff or ff detected. If the genotype FF of the VDR gene polymorphism Fok-I is detected, the VDR gene polymorphism ApaI, BsmI and TaqI are studied additionally. If having at least one of the VDR genotypes AA, Aa ApaI, BB, Bb BsmI and Tt, tt TaqI detected, the postpartum osteopenic syndrome is predicted to develop.
EFFECT: presented method enables predicting the developing postpartum osteopenic syndrome even before the onset of pregnancy, or at any gestational age.
10 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF DEVELOPING POSTPARTUM OSTEOPENIC SYNDROME | 2011 |
|
RU2456599C1 |
METHOD FOR PREDICTION OF RISK OF GENITAL PROLAPSE IN WOMEN | 2023 |
|
RU2823209C1 |
METHOD FOR PREDICTION OF GROWTH OF NEWBORNS USING DATA ON GENETIC POLYMORPHISM OF MOTHERS | 2023 |
|
RU2820498C1 |
METHOD FOR PREVENTING PREECLAMPSIA IN PATIENTS WITH AN AGGRAVATED OBSTETRIC ANAMNESIS | 2016 |
|
RU2663593C2 |
METHOD FOR PREDICTION OF NEWBORN'S WEIGHT BASED ON GENETIC DATA OF MOTHERS | 2023 |
|
RU2818358C1 |
METHOD FOR PREDICTION OF RISK OF DEVELOPING GENITAL PROLAPSE IN PRE-CLINICAL PAROUS WOMEN | 2023 |
|
RU2826543C1 |
METHOD OF PREDICTING THE RISK OF OSTEOARTHRITIS OF THE KNEE JOINT IN WOMEN BASED ON MOLECULAR GENETIC TESTING | 2023 |
|
RU2796897C1 |
METHOD FOR PREDICTION OF NEWBORN'S WEIGHT TAKING INTO ACCOUNT POLYMORPHIC VERSION OF 10976 G/AFVII LOCUS | 2014 |
|
RU2557952C1 |
METHOD OF PREDICTING RISK OF CALCIFICATION OF BIOLOGICAL PROSTHESIS OF HEART VALVES, IMPLANTED IN MITRAL POSITION, BASING ON GENOMIC PREDICTORS | 2016 |
|
RU2616507C1 |
METHOD FOR PREVENTING MENSTRUAL DISORDERS IN GIRLS | 2016 |
|
RU2660341C2 |
Authors
Dates
2015-07-27—Published
2013-12-27—Filed